The tumor suppressor Smad4/DPC4 is an essential transcription factor in the TGF-β pathway that was previously thought to function constitutively. We recently reported that Smad4 activity and stability are directly regulated by 2 major signaling pathways, RTK/MAPK and Wnt/GSK3. Here we examine the molecular, cellular, and potential therapeutic significance of these findings.
CITATION STYLE
Demagny, H., & De Robertis, E. M. (2016). Smad4/DPC4: A barrier against tumor progression driven by RTK/Ras/Erk and Wnt/GSK3 signaling. Molecular and Cellular Oncology, 3(2). https://doi.org/10.4161/23723556.2014.989133
Mendeley helps you to discover research relevant for your work.